All Comments by

  1. Rakez Kayed on Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model.
  2. Suhail Rasool on San Diego: The Future of AD—Can We Vaccinate?
  3. Moustapha Cisse on Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
  4. Lary Walker on Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
  5. Sergio Ferreira on Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation.
  6. Diana Frechilla on Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
  7. Alexander Drzezga on APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.
  8. Pascale Lacor on Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
  9. Lennart Mucke on Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
  10. John Steele on Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice.
  11. Ronit Sharon on A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain.
  12. Nikolaos K. Robakis on Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
  13. Michael Nichols on San Diego: Flexible N-Termini Key to Aβ42 Oligomer Toxicity?
  14. Roxanne Ol on San Diego: TDP-43 Targets Loom Large—But Where’s the Bull’s Eye?
  15. Jens Pahnke on Paper Alert: In Vivo Human Data Shows Reduced Aβ Clearance in AD